Objective: To evaluate the antioxidant and antiproliferative effect of methanolic bee pollen extract (BPE) of Malaysian stingless bee [Lepidotrigona terminata (L. terminata)] and its synergistic effect with cisplatin (a chemotherapeutic drug) on MCF-7 cancer cell line. Methods: The antioxidant activity of BPE from L. terminata was measured by using 1,1-diphenyl-2-picrylhydrazyl radical (DPPH) assay. Antiproliferative activity at different concentrations of BPE and cisplatin was determined through using MTT assay on MCF-7 and L929 cell lines. An interaction effect (synergistic, additive and antagonistic) between BPE and cisplatin was determined by CompuSyn software based on MTT assay data. Results: The EC 50 (50% decrement of DPPH inhibition) of BPE was 0.5 mg/mL. L. terminata BPE exhibited antiproliferative activity on both cancer and normal cell lines. The IC 50 (concentration of drug that was required for 50% of cell inhibition in vitro) of BPE on MCF-7 was 15 mg/mL whereas in normal cell line L929 was 26 mg/mL. The IC 50 for cisplatin on MCF-7 was 20 µmol/L. The combination effect of BPE and cisplatin on MCF-7 cells showed that BPE at 15 mg/mL was able to potentiate the inhibitory effect of cisplatin at all different concentrations (2.5-20.0 mg/mL). The average of cancer cells inhibition which was potentiated by BPE was around 50%. A combination index values of less than 1 reported in the CompuSyn software further proved the synergistic effect between BPE and cisplatin, suggesting that BPE was working synergistically with cisplatin.
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Introduction
Bee pollen is considered as a functional food due to its compositions of carbohydrates, proteins, amino acids, lipids, sugars, fibres, vitamins and mineral salts [1, 2] . It is a collection of pollen grains collected by the bees from various botanical sources, mixed with nectar and secretion from the hypopharyngeal glands such as β-glycosidase enzymes.
Its beneficial effect on health is due to the presence of phenolic compounds with high antioxidant activities [1, 3] .
Oxidative damage and carcinogenesis may gradually lead to the formation of tumors through several mechanisms.
Polyphenols present in bee pollen and other bee products contain antioxidant and antiproliferative activities that can regulate cell proliferation and induce apoptosis [4] . Bee pollen has the antioxidative capacity and the ability to neutralize active oxygen species, extensively due to the action of polyphenols combination. Previous studies have demonstrated that bee pollen can inhibit tumor growth and alleviate the pain of chemotherapy in cancer patients [5, 6] .
In China, bee pollen of Brassica campestris L. (B. campestris) has been widely used as food supplement to strengthen body resistance against cancer [7] . A steroid fraction of bee pollen chloroform extract of B. campestris was shown to strongly induce apoptosis in human prostate cancer PC-3 cells [7] . A study by Izuta et al. showed that bee pollen was able to suppress cells proliferation in in vitro model of vascular endothelial growth factor-induced human umbilical vein endothelial cells proliferation and migration [8] . Constituents of bee pollen such as polysaccharides were also shown by Wang et al. to have significant antiproliferative activity in colon cancer cell lines [5] . Thus the aim of the study is to evaluate the antiproliferative activity of bee pollen extract (BPE) from Malaysian stingless bee, Lepidotrigona terminata (L. terminata) and its effect when combined with cisplatin on MCF-7 cancer cell lines.
Materials and methods
Samples and reagents
Bee pollen or bee bread sample was acquired from a local stingless bee company, K.B meliponini. The source of bee pollen was from the species of L. terminata. The species was identified by the Entomology Section, Malaysian Agriculture and Research Development Institute, Serdang, Malaysia. Bee pollen sample was dried at 37 °C for two consecutive days and once dried, was kept at 4 °C until further use.
Bee pollen crude extract
The crude BPE was prepared by using modified method from LeBlanc et al. by extracting 10 g of bee pollen in 25 mL of 100% methanol [9] . The mixture was vortexed for 10 min and sonicated for 1 h at 41 °C before kept overnight at M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 4 °C . The mixture was then centrifuged at 6 000 r/min for 10 min and the precipitation was discarded. The supernatant was filtered by using a 0.2 µm sterile filter unit (Millipore, USA). Once filtered, it was dried in the rotary evaporator at 41 °C and freeze dried. The freeze dried BPE was kept at 4 °C until further analysis.
Antioxidant activity
The free radical-scavenging capacity of bee pollen methanolic extract was determined by its ability to bleach the stable 1,1-diphenyl-2-picrylhydrazyl radical (DPPH) and was expressed as the percentage of its neutralization. A modification of a method reported by Baharum et al. was employed [10] . The reaction mixture contained 150 µL of DPPH (600 µmol/L) with 7.5 µL of different concentrations of BPEs (3.125, 6 .250, 12.500, 25.000, 50.000 and 100.000 mg/mL). The final concentrations of bee pollen were 0.15, 0.30, 0.60, 1.20, 2.40 and 4.80 mg/mL. After 30 min at room temperature, the reaction mixture was measured by the absorbance at λ = 517 nm. Trolox, a watersoluble derivative of vitamin E at concentration of 25-600 µmol/L, was used as standard. DPPH free radical scavenging activity was calculated through using the following formula: ) and then incubated with 1 mL of 0.25% trypsin for 2 min. The flask was gently tapped to detach them from the plastic surface. Five milliliters of medium was added to the cell suspension while the remaining cells were vigorously washed from the bottom of the culture vessel. The suspended cells were then collected in a 15 mL centrifuge tube and an aliquot of 10 µL was taken out prior centrifugation for cell count by using haemocytometer.
Cell counts
The number of cells per milliliter and the total cell number were calculated. Subsequently after centrifugation, an appropriate volume of complete medium was added to the cell pellet.
Preparation of compound treatments
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BPE stock solution (100 mg/mL) was prepared by diluting 0.1 g of crude extracts in 1 mL DMEM. The solution was then filtered by using a 0.2 µL sterile filter unit (Millipore, USA) and diluted with culture medium to the final concentration of 2.5 mg/mL, 5 mg/mL, 10 mg/mL, 20 mg/mL and 40 mg/mL for treatments.
Cisplatin stock solution (10 mol/L) was prepared by dissolving 6 mg of cisplatin (molecular weight = 300.01 g/moL) in 2 mL DMEM. The stock solution was then diluted with culture medium to the final concentration of 2.5 µmol/L, 5 µmol/L, 10 µmol/L, 20 µmol/L and 40 µmol/L for treatments. The working solutions of the drug were freshly prepared prior usage.
Cytotoxicity determination by using MTT assay
Briefly, the cells were seeded at density of 1 × 
Statistical analysis
All values were expressed as the mean ± SD. The differences in the mean of treated and untreated cells were analysed by using IBM SPSS Statistics 22 (US).
Results
Antioxidant capacity of BPE
In this study, the antioxidant activity of methanolic crude extract of L. terminata BPE measured by using DPPH assay showed a concentration dependent manner in the dose response curve (Figure 1 ). The EC 50 (50% decrement of DPPH inhibition) of BPE was 0.5 mg/mL.
Antiproliferative effect in vitro
The potential antiproliferative effect of BPE was assayed by using the surrogate cell viability MTT assay. Crude BPE was shown to inhibit the growth of both cancer and normal cell lines. The inhibition of cell growth on the breast cancer MCF-7 and normal L929 cell lines by BPE of L. terminata was in dose-dependent manner (Figure 2 ). The IC 50 of BPE on MCF-7 was 15 mg/mL, whereas in normal cell line was 26 mg/mL. BPE at 20 mg/mL inhibited 70% of cell viability in the MCF-7 cells (Figure 2A ) whereas in normal L929 cell lines, inhibition of 70% of cell viability was observed with much higher concentration of 40 mg/mL ( Figure 2B ).
Cytotoxic synergism of BPE with chemotherapy drug
To determine the combination effect of BPE and cisplatin (an anticancer chemotherapy drug), we have designed a non-constant combination treatment of cisplatin and BPE on MCF-7 cells. Serial concentrations of cisplatin were combined with the fixed concentration of BPE at 15 mg/mL. Higher MCF-7 cells inhibition was seen in BPE (15 mg/mL) and cisplatin at all concentrations when compared to cisplatin alone. BPE combination with 2.5 µmol/L cisplatin inhibited 55% of MCF-7 cells proliferation when compared with 2.5 µmol/L cisplatin alone. Whereas BPE in combination with 20 µmol/L cisplatin could further reduce cell proliferation up to 76% compared to 52% reduction M A N U S C R I P T
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seen in treatment of 20 µmol/L cisplatin alone, although it was not statistically significant. The result showed that the BPE was able to potentiate the inhibitory effect of cisplatin in breast cancer cells when combined with cisplatin at all concentrations ( Figure 3) .
To further confirm the interaction between cisplatin and BPE, the data was computed in DPPH inhibition of 1 mg/mL methanolic BPE from L. terminata [13] . However, the result of this study showed lower inhibition than that of Silva et al. which reported that crude BPE from the Brazilian stingless bee species Melipona rufiventris at concentration 0.1 mg/mL was shown to exhibit 50% DPPH inhibition [14] .
The difference in antioxidant activity seen in our study could be due to the difference of the solvent used (methanol in this study vs. ethanol in the study by Silva et al.) , which may give different compounds extraction efficacy, therefore contributed to the different chemical activities [14, 15] . Furthermore specific pollen foraging activities, different pollen species and different diets of stingless bee itself may give different compounds activities found in BPE [14, 16] . Previous studies have shown that bee pollen has good antioxidant properties related to the presence of phenolic compounds [2, 17] .
The antiproliferative activity of L. terminata BPE against MCF-7 and L929 cell lines was evaluated by using MTT assay. The concentration of BPE required to inhibit 50% of MCF-7 cells growth was 15 mg/mL. At 20.0 mg/mL, 70%
inhibition of MCF-7 cells was seen. Whereas in normal L929 cell line, 26 mg/mL was required to exhibit 50% cells inhibition. The response different between normal and cancer cells may suggest that BPE can be relatively safe in normal cells and considered to be a useful agent for anticancer application in future. The much lower IC 50 of BPE in cancer cells suggests that BPE may be specifically targeting the MCF-7 cancer cells.
Similar antiproliferative effect of BPE had been reported in the study by Kustiawan et al. by using four stingless bee species [18] . The result revealed that all four species were cytotoxic to different cell lines tested although their antiproliferative activities were rather low compared to the chemotherapeutic drugs used. Another study by Wu and
Lou also showed strong antiproliferative activity of B. campestris bee pollen chloroform extract in inducing apoptosis in human prostate cancer [7] . The observed cytotoxic activity exhibited by bee pollen varied with the different solvent used, bee species and different cell lines.
In cytotoxic synergism assay, the average of MCF-7 cells inhibition by BPE in combination of cisplatin was around M A N U S C R I P T
50%. This study shows that BPE is able to potentiate and enhance the cisplatin effect on MCF-7 cells at all concentrations.
Active compounds in the BPE might either enhance (synergistic) or decrease (antagonistic) the therapeutic activity of chemotherapy drugs. There was a great concern that some compounds present in the natural product might work antagonistically instead of synergistically with the therapeutic activity of drugs [19] . In this study, CI values reported in all interactions between BPE and cisplatin were less than 1. These CI values further proved the synergistic effect between the two compounds.
This study may suggest that BPE from Malaysian stingless bee L. terminata can be used to supplement the chemotherapeutic agents due to its antiproliferative activitiy and its ability to enhance the effect of chemotherapy agent, even at low concentration. In a recent review by Komosinska-Vassev et al., bee pollen supplement can help to improve the condition of early prostate cancer when given together with chemotherapeutic drug [20] . Furthermore, bee pollen as supplement can be combined with chemotherapy treatment to treat side effects of cancer as reported in a recent study by Salles et al. which showed that bee pollen was able to improve muscle mass and metabolism in undernourished rats [21] . Decreasing muscle mass and poor metabolisms were commonly seen in patients with cancer [22] . The combination of chemotherapy drug and natural product such as BPE may be potentially effective in cancer treatment in future.
The data of this study suggest that bee pollen extract of Malaysian stingless bee is a potential chemopreventive agent and can be used as a supplement during chemotherapy treatment. The same data indicate that BPE works synergistically with chemotherapy drug, cisplatin and enhances the effect of cisplatin even at lower concentration. The molecular mechanisms of how the BPE exerts its antiproliferative and synergistic activities with cisplatin will be a promising area to further explore in future studies.
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